Depixus
Biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins.
Depixus has raised €31M across 1 funding round from 4 investors, most recently a Series A round in Dec 2021. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.depixus.com ↗
Total raised
€31M
€31,227,946
Funding rounds
1
Investors
4
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearDepixus — funding by year — interactive chart.
Data table
| Depixus — funding by year | |
|---|---|
| 2021 | €31M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-16 | Series A | €31M | Arix Bioscience,Casdin Capital,Lansdowne Partners,PSIM fund | View deal → |
Related news
- Depixus Raises USD35.4M in Series A Financingfinsmes.com · 2021-12
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData